Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States-Reference-Cited by-同舟云学术

Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States

Published:2021-07-21 Issue:10 Volume:61 Page:2885-2897
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Earnshaw Stephanie¹^ORCID,Beyhaghi Hadi²,McDade Cheryl¹,Purser Molly³,Marriott Robert⁴,Daane Lori⁵,Le Coent Virginie⁶,Yang Julie⁵,Toback Seth²

Affiliation:

1. Health Economics RTI Health Solutions Research Triangle Park North Carolina USA

2. Medical Affairs Novavax Inc Gaithersburg Maryland USA

3. Value Evidence and Outcomes GlaxoSmithKline LLC Upper Providence Pennsylvania USA

4. Laboratory Operations Consulting Marriott Quality and Performance Solutions LLC Raleigh NC USA

5. Industry Healthcare Division bioMérieux, Inc. Chicago Illinois USA

6. Industry Healthcare Division bioMérieux SA Craponne France

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16589

Reference44 articles.

1. FDA.Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. Guidance for industry. Food and Drug Administration (FDA). 2020.https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/bacterial‐risk‐control‐strategies‐blood‐collection‐establishments‐and‐transfusion‐services‐enhance. Accessed 26 Jan 2021.

2. Improving the safety of platelets by increasing the sample volume and time for sampling and issuing – bacteriological results;Bernier F;Vox Sang,2018

3. Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure

4. Bacterial culture of platelets with the large volume delayed sampling approach: a narrative review

5. A review of testing strategies for bacterial risk control in platelets recommended by the FDA;Vallejo RP;J Clin Haematol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supporting platelet inventory management decisions: What is the effect of extending platelets’ shelf life?;European Journal of Operational Research;2023-10

2. Safety Analysis of Extended Platelet Shelf-Life with Large-Volume Delayed Sampling on BACT/ALERT® VIRTUO® in Australia;Microorganisms;2023-09-19

3. Increased frequency of false‐positive bacterial detection after implementation of new guidelines for large‐volume delayed sampling of platelets;Transfusion;2023-07-15

4. Drivers of consumers’ behavioral intention toward private umbilical cord blood banking: a review;Cell and Tissue Banking;2022-12-19

5. Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies;Pathogens;2022-01-24